1-3 of 3
Jelena Jelicic
Close
Sort by
Journal Articles

A Population-Based Study on Performance of Clinical Prognostic Models in Patients with Diffuse Large B-Cell Lymphoma Younger Than 70 Years

Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Peter de Nully Brown, Tarec Christoffer Christoffer El-Galaly, Thomas Stauffer Larsen
Journal: Blood
Blood (2023) 142 (Supplement 1): 190.
https://doi.org/10.1182/blood-2023-182606
Published: 2023
Journal Articles

Outcome after 3 rd Line Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study

Ahmed Ludvigsen Al-Mashhadi, Lasse Hjort Jakobsen, Peter de Nully Brown, Anne Ortved Gang, Anne-Luise Thorsteinsson, Kaziwa Rasoul, Judith Melchior Heissmann, Michael Buch Tøstesen, Mette Nieman Christoffersen, Jelena Jelicic, Jennifer Bøgh Jørgensen, Troels Thomsen, Andriette Dessau-Arp, Andreas PH Andersen, Mikael Frederiksen, Per Troellund Pedersen, Michael Roost Clausen, Judit Jørgensen, Christian Bjørn Poulsen, Tarec Christoffer Christoffer El-Galaly, Thomas S. Larsen
Journal: Blood
Blood (2022) 140 (Supplement 1): 6706–6707.
https://doi.org/10.1182/blood-2022-167897
Published: 2022
Journal Articles

Is It Possible to Omit Bone Marrow Biopsy in Diagnostic Workup in Patients with Newly Diagnosed Primary CNS Lymphoma? a Retrospective Analysis in the PET/CT Era

Jelena Jelicic, Dennis Lund Hansen, Sarah Sand Carlsen, Michael Thorsgaard, Ditte Hersby, Karina Kannik, Amalie Emilie Munksgaard, Thomas S. Larsen, Karen Juul-Jensen
Journal: Blood
Blood (2022) 140 (Supplement 1): 1334–1335.
https://doi.org/10.1182/blood-2022-165416
Published: 2022